Study to Evaluate Pharmacokinetic and Pharmacodynamic Drug Interactions and Safety of IY-HCR21 and IY-MIC
PHASE1Active, not recruitingINTERVENTIONAL
Enrollment
60
Participants
Timeline
Start Date
June 10, 2024
Primary Completion Date
June 25, 2024
Study Completion Date
July 2, 2024
Conditions
Pharmacokinetics
Interventions
DRUG
IY-HCR21
Betanechol 50mg
DRUG
IY-MIC
Betanechol 25mg
Trial Locations (1)
08756
H plus Yangji Hospital, Seoul
All Listed Sponsors
lead
Il-Yang Pharm. Co., Ltd.
INDUSTRY
NCT06471868 - Study to Evaluate Pharmacokinetic and Pharmacodynamic Drug Interactions and Safety of IY-HCR21 and IY-MIC | Biotech Hunter | Biotech Hunter